Medical Insiders: Overcoming Barriers to the Timely Identification and Treatment of OUD in Rural Communities
Carolyn Baird, DNP, MBA, RN-BC, CARN-AP, CCDPD/CAADC, FIAAN
Counseling and Trauma Services, LLC
Elenore Bhatraju, MD, MPH
Department of Internal Medicine
Evergreen Treatment Services
Edwin A. Salsitz, MD, DFASAM
Unit Chief Physician
Department of Psychiatry and Behavioral Sciences
Mount Sinai Beth Israel
Assistant Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, NY
Julie Blum, PhD
Senior Clinical Content Manager
Kathryn Schaefer, MSN, RN
Lead Nurse Planner
Upon completion, participants should be able to:
- Describe the risk factors associated with OUD in rural communities
- Outline strategies to overcome barriers to identifying and treating OUD
- Implement strategies to effectively identify patients with OUD and assess their readiness for behavioral change
This activity is intended for US-based primary care physicians, physician assistants, nurse practitioners, and nurses practicing in rural settings.
Statement of Need
As a result of skyrocketing rates of opioid misuse, there has been a significant rise in the number of people affected with opioid use disorder (OUD), a condition associated with high morbidity and mortality. Although effective pharmacologic treatments are available for OUD, evidence suggests that these medication-assisted treatments (MATs) are underutilized in clinical practice. Studies indicate that clinician-related barriers hinder the adoption of MATs in clinical practice, including stigma regarding addiction and treatment, lack of knowledge regarding the effectiveness of MATs, and lack of familiarity with best prescribing practices. In particular, data indicate that rural clinicians face unique challenges in providing high-quality opioid abuse treatment that their urban colleagues do not, such as access to specialists and resources. In addition, just 3% of the rural clinicians who service more than 30 million rural Americans have obtained waivers to prescribe buprenorphine to treat OUD. Furthermore, clinicians may miss opportunities to identify prescription drug abuse and addiction in the clinic without specific training on that topic. To meet these needs, this activity will educate rural clinicians about strategies to effectively address opioid addiction within their practice setting.
Provided by Med-IQ. Endorsed by NRHA.
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Med-IQ designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Med-IQ is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This nursing activity has been approved for up to 0.75 contact hour.
Physician assistants and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.
Instructions to Receive Credit
To receive credit, read the introductory CME/CE material, watch the Webcast, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
Initial Release Date: December 22, 2017
Expiration Date: December 21, 2018
Estimated Time to Complete This Activity: 45 minutes
The evaluation, attestation, and post-test may be accessed by clicking the “Get Credit” tab at the bottom of the Webcast activity.
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.
Carolyn Baird, DNP, MBA, RN-BC, CARN-AP, CCDPD/CAADC, FIAAN, has indicated no real or apparent conflicts.
Elenore Bhatraju, MD, MPH, has indicated no real or apparent conflicts.
Edwin A. Salsitz, MD, DFASAM, has indicated no real or apparent conflicts.
The peer reviewers and activity planners have no financial relationships to disclose.
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
For questions or comments about this activity, please contact Med-IQ.
Call (toll-free) 866 858 7434 or e-mail email@example.com.
Microsoft Windows® 8, Windows 7
Mac OS 10.7 (Lion) or newer
Microsoft Internet Explorer 8.0 or later
Mozilla Firefox - latest version
Google Chrome - latest version
Apple Safari - latest version
Adobe Acrobat Reader® or Adobe Reader
Adobe Flash Player
Adobe Flash Player 9 or later
For technical support, go to http://www.med-iq.com/index.cfm?fuseaction=content.support.
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy notice, please visit: www.med-iq.com/privacy-statement/.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Indivior, Inc.
© 2017 Med-IQ, LLC
Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.